RecruitingNCT07325864

Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site


Sponsor

European Institute of Oncology

Enrollment

25 participants

Start Date

Dec 18, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

investigate the molecular differences between primitive lung cancer and the metastatic site.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study aims to better understand the genetic make-up of lung cancers and how the primary tumor compares to cancer that has spread to other parts of the body. By analyzing tumor DNA with advanced gene sequencing, researchers hope to improve how lung cancer is treated in a more personalized way. **You may be eligible if...** - You are 18 years or older and healthy enough to tolerate surgery - Your surgical risk has been assessed as low based on heart and lung function - You are willing to follow the study procedures - Tumor tissue can be collected and used for DNA analysis and genetic testing **You may NOT be eligible if...** - You are a woman who is pregnant, breastfeeding, or planning to become pregnant during the study - You have another illness or physical condition that makes participation unsafe - You have a recent or ongoing severe infection Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Istituto Europeo di Oncologia

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07325864


Related Trials